Crunch time for GlaxoSmithKline's big heart drug bet

[riky]

Crunch time for GlaxoSmithKline's big heart drug bet

By Ben Hirschler LONDON (Reuters) - Cardiologists and shareholders in GlaxoSmithKline are about to learn if a big gamble on a new kind of heart medicine has paid off, with modest expectations creating a potentially big share price boost if the news is good. Britain's biggest drugmaker hopes its once-daily pill darapladib can prevent heart attacks and strokes by fighting clogged arteries in a completely different way from cholesterol-lowering drugs.

Source: You are not allowed to view links. Register or Login